163 related articles for article (PubMed ID: 2693187)
41. The role of ifosfamide in cervical cancer.
Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
[TBL] [Abstract][Full Text] [Related]
42. [Intra-arterial preoperative chemotherapy of advanced cervix cancer].
Knapstein PG; Kreienberg R; Beck T; Mahlke M; Mitze M; Düber C
Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):156-60. PubMed ID: 2040415
[TBL] [Abstract][Full Text] [Related]
43. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
[TBL] [Abstract][Full Text] [Related]
44. [Results of adjuvant chemotherapy of operated high risk cervix carcinoma].
Dimpfl T; Stumpfe M; Baltzer J; Genz T
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):517-9. PubMed ID: 9036063
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response.
Leminen A; Alftan H; Stenman UH; Lehtovirta P
Acta Obstet Gynecol Scand; 1992 May; 71(4):293-7. PubMed ID: 1322623
[TBL] [Abstract][Full Text] [Related]
46. [A clinical study on multiple tumor markers following therapy in patients with uterine cervical carcinoma].
Hiura M; Yorishima M; Tanaka M; Yokoyama T; Myoga H; Chiba T; Nakanishi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):471-8. PubMed ID: 2373919
[TBL] [Abstract][Full Text] [Related]
47. [Tumor markers in patients with head-neck carcinomas].
Walther EK; Dahlmann N; Gorgulla HT
Laryngorhinootologie; 1990 May; 69(5):271-4. PubMed ID: 2354022
[TBL] [Abstract][Full Text] [Related]
48. [Follow-up of tumor markers in evaluating the effectiveness of chemo- or hormone therapy in metastatic breast cancer].
Möbus V; Paula J; Beck T; Crombach G; Kreienberg R
Geburtshilfe Frauenheilkd; 1993 Jan; 53(1):24-9. PubMed ID: 8440454
[TBL] [Abstract][Full Text] [Related]
49. Squamous cell carcinoma of the colon with an elevated serum squamous cell carcinoma antigen responding to combination chemotherapy.
Copur S; Ledakis P; Novinski D; Mleczko KL; Frankforter S; Bolton M; Fruehling RM; VanWie E; Norvell M; Muhvic J
Clin Colorectal Cancer; 2001 May; 1(1):55-8. PubMed ID: 12445380
[TBL] [Abstract][Full Text] [Related]
50. Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy.
Tanioka M; Katsumata N; Yonemori K; Kouno T; Shimizu C; Tamura K; Ando M; Fujiwara Y
Cancer Chemother Pharmacol; 2011 Aug; 68(2):337-42. PubMed ID: 20976599
[TBL] [Abstract][Full Text] [Related]
51. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
Buxton EJ
Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
[TBL] [Abstract][Full Text] [Related]
52. Prediction of clinical course and recurrence of human ovarian cancer by several serum tumor markers.
Kikuchi Y; Kita T; Iwano I; Kuki E; Oomori K; Kizawa I
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):69-76. PubMed ID: 2926196
[TBL] [Abstract][Full Text] [Related]
53. A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix.
Filtenborg TA; Hansen HH; Aage Engelholm S; Rørth M
Ann Oncol; 1993 Jun; 4(6):485-8. PubMed ID: 8353091
[TBL] [Abstract][Full Text] [Related]
54. Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix.
Kodama J; Takemoto M; Seki N; Nakamura K; Hongo A; Moriya S; Kanazawa S; Hiramatsu Y
Int J Gynecol Cancer; 2008; 18(6):1300-4. PubMed ID: 18284451
[TBL] [Abstract][Full Text] [Related]
55. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G
J Clin Oncol; 1994 Nov; 12(11):2309-16. PubMed ID: 7964945
[TBL] [Abstract][Full Text] [Related]
56. [Prediction of the recurrence of squamous cell carcinoma of the uterine cervix by monitoring serum TA-4].
Oishi T; Maruo T; Yamasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):799-806. PubMed ID: 3598275
[TBL] [Abstract][Full Text] [Related]
57. [Combination chemotherapy with ifosfamide, 5-fuluorouracil, etoposide and cisplatin for advanced urothelial cancer: the treatment results and significance of tumor marker evaluation in response assessment of chemotherapy].
Maezawa T; Yonese J; Tsukamoto T; Ishii N; Fukui I
Nihon Hinyokika Gakkai Zasshi; 2002 Nov; 93(7):727-35. PubMed ID: 12494517
[TBL] [Abstract][Full Text] [Related]
58. [Experimental and clinical study on chemotherapy for cervical adenocarcinoma].
Takehara M; Hayakawa O; Kudo R
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):405-12. PubMed ID: 7537322
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
[TBL] [Abstract][Full Text] [Related]
60. [The clinical usefulness of SCC antigen for diagnosis of recurrent cervical squamous cancer].
Umezawa S; Takeshima N; Shimizu Y; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):165-8. PubMed ID: 7706858
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
